This post was just published on ZYX Short Change Alert. If still holding, consider exiting STJ right here. You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES. Please click here to take advantage of a FREE
This post was just published on ZYX Short Change Alert. STJ is a medical device company. It reported earnings yesterday. There are many risks ahead that investors seem to be ignoring. One of the risks is that the accord in Washington did not repeal the medical device tax. Consider adding a
This post was just published on ZYX Short Change Alert. Our algorithms that have been carefully monitoring potential of further short squeezes between now and the year end have just given a signal that the probability of a major short squeeze between now and the year end has significantly increased. In
These posts were just published on ZYX Short Change Alert. STJ reported earnings that are slightly better than expectations. Our short thesis has to do with the quality of the products and its resulting negative effects on the company’s reputation. Our thesis remains intact. However, in this bull market it is
This post was published on ZYX Short Change Alert. Consider initiating or adding a 10% tranche to STJ in the zone of $45.30 to $46.20. Stop zone on this tranche is $47.63 to $47.88. Target zone for this tranche is $34. to $36.
This post was just published on ZYX Short Change Alert. STJ makes medical devices primarily related to the heart. There is a new report of deaths related to its leads. Consider adding a 10% tranche in the zone of $46.70 to $47.75 or initiating a 20% tranche in this zone. No
This post was just published on ZYX Short Change Alert. Consider initiating or adding a 10% tranche on any further spike from here in the zone of $42.69 to $43.44. Aggressive investors just initiating the position can consider a 20% tranche. The target zone is $31 to $32. No stops for
This post was just published on ZYX Short Sell Change Alert. The up move in STJ is mostly short covering. Therefore the stop zone is being temporarily suspended. However those not able to handle a short squeeze may want to exit here. The plan is to add more in small tranches
This post was just published on ZYX Short Sell Change Alert. Initiating a 10% tranche in STJ in the zone of $38.30 to $39.20. The stock as of this writing is $38.39. The street is misunderstanding the FDA letter for this medical device manufacturer. Target zone $31. to $32. Stop zone
Obama has been re-elected; “Obamacare” is the law of the land. It doesn’t matter if you agree or disagree with Obamacare, you might as well generate big profits from it. Obamacare has been profitable for us. We bought Amerigroup Corp. AGP at $22.05, and, as of this writing, the stock